Epidemiological characteristics of thyroid cancer in cancer registration areas of Xinjiang Uygur Autonomous Region in 2020 and the trends from 2016 to 2020
1. Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention (Xinjiang Academy of Preventive Medicine), Urumqi, Xinjiang 830000, China; 2. School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830000, China; 3. Karamay Third People's Hospital, Karamay, Xinjiang 834000, China
Abstract：Objective To investigate the trends in incidence and mortality of thyroid cancer in cancer registration areas of Xinjiang Uygur Autonomous Region from 2016 to 2020 and its epidemiological status in 2020, so as to provide the basis for improving prevention and control measures for thyroid cancer. Methods The data of thyroid cancer incidence and mortality from 2016 to 2020 in four cancer registration areas of Xinjiang Uygur Autonomous Region were collected through the Tumor Registry. The crude incidence and crude mortality were calculated. The Chinese population-standardized rate and world population-standardized rate were calculated using the age structure of the standard population from the Fifth National Population Census in 2000 and Segi's world standard population. The incidence and mortality characteristics of thyroid cancer in different genders and ages in 2020 were described. The trends in the Chinese population-standardized incidence and mortality of thyroid cancer in Xinjiang Uygur Autonomous from 2016 to 2020 were assessed using the average annual percent change (AAPC). Results In 2020, the crude, Chinese population-standardized and world population-standardized incidences of thyroid cancer in Xinjiang Uygur Autonomous Region were 32.91/105, 26.99/105, and 25.53/105, respectively. The crude, Chinese population-standardized and world population-standardized mortalities of thyroid cancer were 1.25/105, 0.96/105, and 0.98/105, respectively. The Chinese population-standardized incidence and mortality of thyroid cancer in females were 2.44 times and 2.20 times those in males, respectively. The crude incidence of thyroid cancer was increased after age of twenty years, with a peak at age of 55 to 60 years (76.73/105) before rapidly declining. In contrast, the crude mortality remained low across all age groups, with the highest rate observed at age of 70 to 75 years (13.70/105). From 2016 to 2020, the Chinese population-standardized incidence and mortality of thyroid cancer showed no significant changes (both P>0.05). Conclusions From 2016 to 2020, the trends in incidence and mortality of thyroid cancer in cancer registration areas of Xinjiang Uygur Autonomous Region were stable. The disease burden of thyroid cancer was higher in females than in males. The crude incidence first rised and then declined with age, peaks at age of 55-<60 years.
阿迪拉·苏力旦, 夏依达·乌斯满江, 沙吾拉西·热加甫, 夏木斯叶·木依都力, 张俊, 达娜古丽·玛拉, 依力夏提·库来西, 阿不力米提·木合塔尔, 张荣. 2020年新疆肿瘤登记地区甲状腺癌流行特征及2016—2020年变化趋势分析[J]. 预防医学, 2025, 37(10): 1020-10,231,028.
Adila Sulidan, Xiayida Wusimanjiang, Shawulaxi Rejiafu, Xiamusiye Muyiduli, ZHANG Jun, Danaguli Mala, Yilixiati Kulaixi, Abulimiti Muhetaer, ZHANG Rong. Epidemiological characteristics of thyroid cancer in cancer registration areas of Xinjiang Uygur Autonomous Region in 2020 and the trends from 2016 to 2020. Preventive Medicine, 2025, 37(10): 1020-10,231,028.
[1] ZHANG L,JIANG L L,XU R,et al.Epidemiological study of thyroid cancer at global,regional,and national levels from 1990 to 2021:an analysis derived from the Global Burden of Disease Study 2021[J/OL].Front Endocrinol(Lausanne),2025,16[2025-09-22].https://doi.org/10.3389/fendo.2025.1644270. [2] 姚承志,张译匀,吴霞,等.1990—2019年全球甲状腺癌发病现状分析及2020—2030年发病趋势预测[J].中国肿瘤,2023,32(11):848-855. YAO C Z,ZHANG Y Y,WU X,et al.Analysis of worldwide thyroid cancer incidence from1990 to 2019 and trend prediction from 2020 to 2030[J].China Cancer,2023,32(11):848-855.(in Chinese) [3] 苏未,顼禹同,王一诺,等.1990至2019年中国与全球甲状腺癌疾病负担比较分析[J].中国医学科学院学报,2023,45(6):940-948. SU W,XU Y T,WANG Y N,et al.Comparison of disease burden factors of thyroid cancer between China and the world from 1990 to 2019[J].Acta Acad Med Sin,2023,45(6):940-948.(in Chinese) [4] 杨道余,金亦荣,洪仙月,等.苍南县甲状腺癌危险因素的病例对照研究[J].预防医学,2019,31(4):385-389. YANG D Y,JIN Y R,HONG X Y,et al.A case-control study on risk factors of thyroid cancer in Cangnan County[J].China Prev Med J,2019,31(4):385-389.(in Chinese) [5] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [6] 贾海晗,孙惠昕,张茂祥,等.2013—2017年黑龙江省肿瘤登记地区甲状腺癌流行趋势[J].中华肿瘤防治杂志,2022,29(6):387-392. JIA H H,SUN H X,ZHANG M X,et al.Analysis on the trend of thyroid cancer prevalence in tumor registration areas of Heilongjiang Province from 2013 to 2017[J].Chin J Cancer Prev Treat,2022,29(6):387-392.(in Chinese) [7] 马晶昱,相智声,林永添,等.2011—2020年福建省肿瘤登记地区甲状腺癌流行特征及变化趋势[J].实用肿瘤学杂志,2023,37(4):301-307. MA J Y,XIANG Z S,LIN Y T,et al.Epidemic characteristics and changing trends of thyroid cancer in cancer registration areas of Fujian Province from 2011 to 2020[J].Pract Oncol J,2023,37(4):301-307.(in Chinese) [8] 李佳佳,张小鹏,张俊青,等.2021年安徽省合肥市甲状腺癌流行特征及2013—2021年变化趋势分析[J].中国肿瘤,2025,34(3):188-194. LI J J,ZHANG X P,ZHANG J Q,et al.Incidence and mortality of thyroid cancer in Hefei City,Anhui Province in 2021 and the trend from 2013 to 2021[J].China Cancer,2025,34(3):188-194.(in Chinese) [9] 王杨凤,刘君.2016—2020年涪陵区甲状腺癌发病趋势[J].预防医学,2022,34(5):511-514. WANG Y F,LIU J.Trends in incidence of thyroid cancer in Fuling District from 2016 to 2020[J].China Prev Med J,2022,34(5):511-514.(in Chinese) [10] 马珠媛,闫纳,丁高恒,等.2019年甘肃省肿瘤登记地区甲状腺癌流行特征及2010—2019年变化趋势分析[J].中国肿瘤,2024,33(11):922-929. MA Z Y,YAN N,DING G H,et al.Epidemic characteristics of thyroid cancer in Gansu cancer registration areas in 2019 and trends from 2010 to 2019[J].China Cancer,2024,33(11):922-929.(in Chinese) [11] 苏幸,郑琳,章华米,等.2010—2020年浙江省杭州市西湖区甲状腺癌发病特征和流行趋势分析[J].疾病监测,2022,37(10):1367-1370. SU X,ZHENG L,ZHANG H M,et al.Thyroid cancer incidence trend in Xihu district,Hangzhou,2010-2020[J].Dis Surveill,2022,37(10):1367-1370.(in Chinese) [12] FERNANDES-TAYLOR S,BOWLES E J A,VENKATESH M,et al.Differential ultrasound rates mirror sex disparities in thyroid cancer[J].Thyroid,2024,34(12):1531-1539. [13] SINHA S H,HAYMART M R.Examining why thyroid cancer incidence is high in women[J].Thyroid,2024,34(12):1449-1450. [14] 裘凤黔,杜娟,纪云芳,等.2002—2017年黄浦区甲状腺癌发病趋势[J].预防医学,2022,34(1):83-86. QIU F Q,DU J,JI Y F,et al.Trends in incidence of thyroid cancer in Huangpu District from 2002 to 2017[J].China Prev Med J,2022,34(1):83-86.(in Chinese) [15] SHAO Y H,TSAI K,KIM S,et al.Exposure to tomographic scans and cancer risks[J/OL].JNCI Cancer Spectr,2020,4[2025-09-22].https://doi.org/10.1093/jncics/pkz072. [16] 付金蓉,关海霞.老年甲状腺结节的诊治进展[J].老年医学与保健,2021,27(4):861-864. FU J R,GUAN H X.Progress in diagnosis and treatment of thyroid nodules in elderly patients[J].Geriatr Health Care,2021,27(4):861-864.(in Chinese) [17] HAYMART M R.Understanding the relationship between age and thyroid cancer[J].Oncologist,2009,14(3):216-221. [18] 张丽娜,倪文婧,张梦杰,等.适碘地区老年人甲状腺结节的患病率及危险因素调查[J].重庆医科大学学报,2024,49(1):24-30. ZHANG L N,NI W J,ZHANG M J,et al.Prevalence and risk factors of thyroid nodules in the elderly in iodine-sufficient areas[J].J Chongqing Med Univ,2024,49(1):24-30.(in Chinese)
